Comparing with those of hepatic-pancreatic-biliary origins, gastric gastrinomas had significantly higher gastrin levels but smaller tumor size, lower ki-67 proliferation index, and more well-differentiated tumors (G1). The gene discussed is GAST; the disease is gastric gastrin-producing neuroendocrine tumor.